A new mixture design-based approach to graphical screening of potential interconnections and variability processes in metabolic systems

Chemical Biology and Drug Design

Volumn 75, Issue 1, 2010, Pages 91-105

  Semmar, Nabil ^a,b  

^a Medical School of Marseilles   (France)

^b University Tunis El Manar   (Tunisia)

Author keywords

Chemical polymorphism; Hysteresis; Metabolic flexibility; Metabolic pathways; Metabolic profiles; Mixture design; Smoothing

Indexed keywords

DRUG METABOLITE; LEVODOPA;

ARTICLE; CHEMICAL REACTION KINETICS; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); DRUG BIOAVAILABILITY; DRUG DESIGN; DRUG METABOLISM; HUMAN; MAXIMUM PLASMA CONCENTRATION; METABOLOMICS; PRIORITY JOURNAL; REGULATORY MECHANISM; TIME TO MAXIMUM PLASMA CONCENTRATION;

EID: 71449114998     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2009.00912.x     Document Type: Article

References (65)

1. Cruz-Monteagudo M., Munteanu C.R., Borges F., Cordeiro M.N.D.S., Uriarte E., Chou K.C., González-Díaz H. (2008) Stochastic molecular descriptors for polymers. 4. Study of complex mixtures with topological indices of mass spectra spiral and star networks: the blood proteome case. Polymer 49 : 5575 5587.
2. González-Díaz H., González-Díaz Y., Santana L., Ubeira F.M., Uriarte E. (2008) Proteomics, networks and connectivity indices. Proteomics 8 : 750 778.
3. Todeschini R., Consonni V. (2000) Handbook of Molecular Descriptors. Weinheim : Wiley-VCH.
4. González-Díaz H., de Armas R.R., Molina R. (2003) Markovian negentropies in bioinformatics. 1. A picture of footprints after the interaction of the HIV-1 -RNA packaging region with drugs. Bioinformatics 19 : 2079 2087.
5. Marrero-Ponce Y., Castillo-Garit J.A., Nodarse D. (2005) Linear indices of the 'macromolecular graph's nucleotides adjacency matrix' as a promising approach for bioinformatics studies. Part 1: prediction of paromomycin's affinity constant with HIV-1 -RNA packaging region. Bioorg Med Chem 13 : 3397 3404.
6. Prado-Prado F.J., Gonzalez-Diaz H., de la Vega O.M., Ubeira F.M., Chou K.C. (2008) Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds. Bioorg Med Chem 16 : 5871 5880.
7. Prado-Prado F.J., de la Vega O.M., Uriarte E., Ubeira F.M., Chou K.C., González-Díaz H. (2009) Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks. Bioorg Med Chem 17 : 569 575.
8. Chou K.C., Cai Y.D. (2006) Predicting protein-protein interactions from sequences in a hybridization space. J Proteome Res 5 : 316 322.
9. Li H., Zhan M. (2006) Systematic intervention of transcription for identifying network response to disease and cellular phenotypes. Bioinformatics 22 : 96 102.
10. Garcia I., Munteanu C.R., Fall Y., Gomez G., Uriarte E., Gonzalez-Diaz H. (2009) QSAR and complex network study of the chiral HMGR inhibitor structural diversity. Bioorg Med Chem 17 : 165 175.
11. Gonzalez-Diaz H., Prado-Prado F.J., Santanaa L., Uriartea E. (2006) Unify QSAR approach to antimicrobials. Part 1: predicting antifungal activity against different species. Bioorg Med Chem 14 : 5973 5980.
12. Prado-Prado F.J., González-Díaz H. (2007) Unified QSAR approach to antimicrobials. Part 2: predicting activity against more than 90 different species in order to halt antibacterial resistance. Bioorg Med Chem 15 : 897 902.
13. Lee J.M., Gianchandani E.P., Papin J.A. (2006) Flux balance analysis in the era of metabolomics. Brief Bioinform 7 : 140 150.
14. Ni T.C., Savageau M.A. (1996) Application of biochemical systems theory to metabolism in human red blood cells. J Biol Chem 271 : 7927 7941.
15. Motter A.E., Gulbahce N., Almaas E., Barabasi A.L. (2008) Predicting synthetic rescues in metabolic networks. Mol Syst Biol 4 : 1 10.
16. Schilling C.H., Edwards J.S., Letscher D., Palsson B. (2001) Combining pathway analysis with flux balance analysis for the comprehensive study of metabolic systems. Biotechnol Bioeng 71 : 286 306.
17. Estrada E., Bodin O. (2008) Using network centrality measures to manage landscape connectivity. Ecol Appl 18 : 1810 1825.
18. Estrada E. (2007) Point scattering: a new geometric invariant with applications from (nano) clusters to biomolecules. J Comput Chem 28 : 767 777.
19. Estrada E. (2006) Protein bipartivity and essentiality in the yeast protein-protein interaction network. J Proteome Res 5 : 2177 2184. (Pubitemid 44330810)
20. Vilar S., Estrada E., Uriarte E., Santana L., Gutierrez Y. (2005) In silico studies toward the discovery of new anti-HIV nucleoside compounds through the use of TOPS-MODE and 2D/3D connectivity indices. 2. Purine derivatives. J Chem Inf Model 45 : 502 514.
21. Ivanciuc O., Balaban T.S., Balaban A.T. (1993) Chemical graphs with degenerate topological indices based on information on distances. J Math Chem 14 : 21 33.
22. Ponce Y.M. (2004) Total and local (atom and atom type) molecular quadratic indices: significance interpretation, comparison to other molecular descriptors, and QSPR/QSAR applications. Bioorg Med Chem 12 : 6351 6369.
23. Yanai I., Baugh L.R., Smith J.J., Roehrig C., Shen-Orr S.S., Claggett J.M., Hill A.A., Slonim D.K., Hunter C.P. (2008) Pairing of competitive and topologically distinct regulatory modules enhances patterned gene expression. Mol Syst Biol 4 : 1 12.
24. González-Díaz H., Vilar S., Santana L., Uriarte E. (2007) Medicinal chemistry and bioinformatics - current trends in drugs discovery with networks topological indices. Curr Top Med Chem 7 : 1025 1039.
25. Gonzalez-Diaz H., Prado-Prado F., Ubeira F.M. (2008) Predicting antimicrobial drugs and targets with the MARCH-INSIDE approach. Curr Top Med Chem 8 : 1676 1690.
26. Cruz-Monteagudo M., Munteanu C.R., Borges F., Cordeiro M.N., Uriarte E., Gonzalez-Diaz H. (2008) Quantitative Proteome-Property Relationships (QPPRs). Part 1: finding biomarkers of organic drugs with mean Markov connectivity indices of spiral networks of blood mass spectra. Bioorg Med Chem 16 : 9684 9693.
27. Cruz-Monteagudo M., González-Díaz H., Borges F., Dominguez E.R., Cordeiro M.N. (2008) 3D-MEDNEs: an alternative "in silico" technique for chemical research in toxicology. 2. Quantitative Proteome-Toxicity Relationships (QPTR) based on mass spectrum spiral entropy. Chem Res Toxicol 21 : 619 632.
28. Nakata K., Tanaka Y., Nakano T., Adachi T., Tanaka H., Kaminuma T., Ishikawa T. (2006) Nuclear receptor-mediated transcriptional regulation in phase I, II, and III xenobiotic metabolizing systems. Drug Metab Pharmacokinet 21 : 437 457.
29. Wodak S.J., Castura J., Orsi C. (2004) Integrative bioinformatics: making sense of the networks. Drug Discov Today: Technol 1 : 179 187.
30. González-Díaza H., Tenoriob E., Castañedob N., Santanaa L., Uriarte E. (2005) 3D QSAR Markov model for drug-induced eosinophilia - theoretical prediction and preliminary experimental assay of the antimicrobial drug G1. Bioorg Med Chem 13 : 1523 1530.
31. Llaneras F., Picó J. (2008) Stoichiometric modelling of cell metabolism. J Biosci Bioeng 105 : 1 11.
32. Steuer R. (2007) Computational approaches to the topology, stability and dynamics of metabolic networks. Phytochemistry 68 : 2139 2151.
33. Papin J.A., Price N.D., Wiback S.J., Fell D.A., Palsson B.O. (2003) Metabolic pathways in the post-genome era. Trends Biochem Sci 28 : 250 258.
34. Papin J.A., Stelling J., Price N.D., Klamt S., Schuster S., Palson B.O. (2004) Comparison of network-based pathway analysis methods. Trends Biotechnol 22 : 400 405.
35. Calik P., Ozdamar T.H. (2002) Metabolic flux analysis for human therapeutic protein productions and hypothesis for new therapeutical strategies in medicine. Biotechnol Eng J 11 : 49 68.
36. Crampina E.J., Schnella S., McSharryd P.E. (2004) Mathematical and computational techniques to deduce complex biochemical reaction mechanisms. Prog Biophys Mol Biol 86 : 77 112.
37. Yang T.H., Wittmann C., Heinzle E. (2004) Metabolic network simulation using logical loop algorithm and Jacobian matrix. Metab Eng 6 : 256 267.
38. Zhan M. (2007) Deciphering modular and dynamic behaviors of transcriptional networks. Genomic Med 1 : 19 28.
39. Ritschel W.A., Kearns G.L. (1999) Handbook of Basic Pharmacokinetics. Washington, DC : American Pharmaceutical Association.
40. Eide I. (1996) Strategies for toxicological evaluation of mixtures. Food Chem Toxicol 34 : 1147 1149.
41. Pattarino F., Marengo E., Gasco M.R., Carpignano R. (1993) Experimental design and partial least squares in the study of complex mixtures: microemulsions as drug carriers. Int J Pharm 91 : 157 165.
42. Nyieredy S., Meier B., Erdelmeier C.A.J., Sticher O. (1985) "PRISMA": a geometrical design for solvent optimization in HPLC. HRC CC J High Resolut Chromatogr Chromatogr Commun 8 : 186 188.
43. Glajch J.L., Kirkland J.J., Snyder L.R. (1982) Practical optimisation of solvent selectivity in liquid-solid chromatography using a mixture-design statistical technique. J Chromatogr 238 : 269 280.
44. Bonifati V., Meco G. (1999) New selective cathecol-O-methyltransferase inhibitors as therapeutic agents in parkinson's disease. Pharmacol Ther 81 : 1 36.
45. Wade L.A., Katzman R. (1975) 3-O-Methyldopa uptake and inhibition of l-dopa at the blood-brain barrier. Life Sci 17 : 131 136.
46. Gervas J.J., Muradás V., Bazán E., Aguado E.G., de Yébenes J.G. (1983) Effects of 3-OM-dopa on monoamine metabolism in rat brain. Neurology 33 : 278 282.
47. Nutt J.G., Fellman J.H. (1984) Pharmacokinetics of levodopa. Neuropharmacol 7 : 35 49.
48. Escofier B., Pagès J. (1991) Presentation of correspondence analysis and multiple correspondence analysis with the help of examples. In : Devillers J., Karcher W., editors. Applied Multivariate Analysis in SAR and Environmental Studies. Dordrecht : Kluwer Academic Publishers p. 1 32.
49. Greenacre M.J. (1984) Theory and Alication of Correspondence Analysis. London : Academic Press.
50. Greenacre M.J., Hartie T. (1987) Theory and alications of correspondence analysis. J Am Stat Assoc 82 : 437 444.
51. Roux M. (1991) Basic procedures in hierarchical cluster analysis. In : Devillers J., Karcher W., editors. Applied Multivariate Analysis in SAR and Environmental Studies. Dordrecht : Kluwer Academic Publishers p. 115 136.
52. Roux M. (1991) Interpretation of hierarchical clustering. In : Devillers J., Karcher W., editors. Applied Multivariate Analysis in SAR and Environmental Studies. Dordrecht : Kluwer Academic Publishers p. 137 152.
53. Semmar N., Bruguerolle B., Boullu-Ciocca S., Simon N. (2005) Cluster analysis: an alternative method for covariate selection in population pharmacokinetic Modeling. J Pharmacokinet Pharmacodyn 32 : 333 358.
54. Sado G., Sado M.C. (1991) Les Plans d'expériences, de l'expérimentation à l'assurance Qualité. Paris : Afnor Technique.
55. Scheffé H. (1958) Experiments with mixtures. J R Stat Soc Series B 20 : 344 360.
56. Scheffé H. (1963) The simplex-centroid design for experiments with mixtures. J R Stat Soc Series B 25 : 235 263.
57. Jerrold H.Z. (1998) Biostatistical Analysis. New Jersey, USA : Prentice Hall.
58. Camacho D., de la Fuente A., Mendes P. (2005) The origin of correlations in metabolomics data. Metabolomics 1 : 53 63.
59. Steuer R. (2006) On the analysis and interpretation of correlations in metabolomic data. Brief Bioinform 7 : 151 158.
60. Murata M. (2006) Pharmacokinetics of l-dopa: special reference to food and aging. J Neurol 253 : 47 52.
61. Nutt J.G. (2000) Response to l-dopa in PD: the long and the short of it. Neurology 54 : 1884 1885.
62. Köhnke M.D., Wiatr G., Kolb W., Köhnke A.M., Schick S., Lutz U., Vonthein R., Gaertner I. (2003) Plasma homovanillic acid: a significant association with alcoholism is independent of functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology 28 : 1004 1010.
63. Shargel L., Yu A.B.C. (1999) Applied Biopharmaceutics and Pharmacokinetics. New York : Mc Graw Hill.
64. Macheras P., Iliadis A. (2006) Modeling in Biopharmaceutics, Pharmacokinetics, and Pharmacodynamics: Homogeneous and Heterogeneous Approaches. New York : Springer.
65. Wildermuth M.C. (2000) Metabolic control analysis: biological applications and insights. Genome Biol 1 : 1031.1 1031.5.